News from us and our partners

Tags

Topics

0 results

News
3 August, 2023
Sensorion completes a private placement of €35 million subscribed by leading US and European biotech investors
News
3 August, 2023
GenSight Biologics obtains funding of €10 million from Sofinnova Partners, Invus and UPMC Enterprises
News
3 August, 2023
Sofinnova Partners’ focus on people and science at the core of investment strategy
News
24 July, 2023
Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumors
News
20 July, 2023
Sangamo and nChroma partner on zinc finger epigenetic editing
News
19 July, 2023
Sensorion submits Clinical Trial Application for OTOF-GT, its lead gene therapy candidate, in Europe
News
12 July, 2023
Tenpoint Therapeutics launches with $70 million Series A financing to reverse vision loss through engineered cell-based therapeutics and in vivo reprogramming
News
11 July, 2023
NodThera is first to demonstrate reduction in neuroinflammation in the clinic with brain penetrant NLRP3 inflammasome inhibitor
News
4 July, 2023
Simon Turner talks digital medicine at LSI USA '23
News
28 June, 2023
Maestro, Moon Surgical's rising star
News
26 June, 2023
May Health announces data from feasibility studies of its novel Ovarian Rebalancing™ treatment and receives approval from FDA for pivotal trial
News
21 June, 2023
Noema Pharma appoints Ilise Lombardo, M.D., as Chief Executive Officer
News
20 June, 2023
CorWave announces second closing of its Series C funding at €61M to finance its first industrial deployment
News
20 June, 2023
Nuage Therapeutics raises €12M in seed financing, led by Sofinnova Partners and Asabys
News
15 June, 2023
F2G receives FDA complete response letter for olorofim NDA
News
8 June, 2023
Production operations at AFYREN NEOXY plant make significant progress, with first lots delivered

Sensorion completes a private placement of €35 million subscribed by leading US and European biotech investors

GenSight Biologics obtains funding of €10 million from Sofinnova Partners, Invus and UPMC Enterprises

Sofinnova Partners’ focus on people and science at the core of investment strategy

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumors

Sangamo and nChroma partner on zinc finger epigenetic editing

Sensorion submits Clinical Trial Application for OTOF-GT, its lead gene therapy candidate, in Europe

Tenpoint Therapeutics launches with $70 million Series A financing to reverse vision loss through engineered cell-based therapeutics and in vivo reprogramming

NodThera is first to demonstrate reduction in neuroinflammation in the clinic with brain penetrant NLRP3 inflammasome inhibitor

Simon Turner talks digital medicine at LSI USA '23

Maestro, Moon Surgical's rising star

May Health announces data from feasibility studies of its novel Ovarian Rebalancing™ treatment and receives approval from FDA for pivotal trial

Noema Pharma appoints Ilise Lombardo, M.D., as Chief Executive Officer

CorWave announces second closing of its Series C funding at €61M to finance its first industrial deployment

Nuage Therapeutics raises €12M in seed financing, led by Sofinnova Partners and Asabys

F2G receives FDA complete response letter for olorofim NDA

Production operations at AFYREN NEOXY plant make significant progress, with first lots delivered